Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

13.210
-0.260-1.93%
Volume:2.40M
Turnover:31.85M
Market Cap:7.85B
PE:-74.52
High:13.540
Open:13.420
Low:13.150
Close:13.470
52wk High:28.600
52wk Low:10.870
Shares:594.00M
HK Float Shares:594.00M
Volume Ratio:1.32
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.177
ROE:-9.57%
ROA:-8.91%
PB:6.11
PE(LYR):-74.52
PS:49.23

Loading ...

Carsgen Therapeutics Climbs on Board Nod for Share Buyback

Reuters
·
Jun 26

CARSGEN-B Announces Share Buyback Plan of Up to 5% of Issued Shares

Stock News
·
Jun 26

Carsgen Therapeutics Holdings - Approves Share Repurchase Plan for up to 30.12 Mln Shares, About 5% of Issued Shares

THOMSON REUTERS
·
Jun 26

High Growth Tech Stocks In Asia To Watch For Potential Expansion

Simply Wall St.
·
Jun 26

Movement Alert|CARsgen Biotech Falls 5.07% in Regular Trading, Fourth Straight Decline After Global First Solid Tumor CAR-T Approval

Market Focus
·
Jun 26

Movement Alert|CARsgen Therapeutics Falls 5.46% in Regular Trading, Stock Under Pressure for Third Consecutive Day After Global First Solid Tumor CAR-T Approval

Market Focus
·
Jun 25

CARSGEN-B Secures World's First CAR-T Therapy for Solid Tumors, Faces Commercialization Test with 990,000 RMB Per Dose

Deep News
·
Jun 25

Movement Alert|CARsgen Therapeutics Falls 6.03% in Regular Trading, Stock Continues Selling Off Despite Historic Solid Tumor CAR-T Approval

Market Focus
·
Jun 24

Movement Alert|CARsgen Therapeutics Intraday Decline 7.49%, Profit-Taking After Historic Solid Tumor CAR-T Approval

Market Focus
·
Jun 23

CARsgen Announces Approval of Satri-Cel, the World's First Car T-Cell Therapy Product for Solid Tumors

THOMSON REUTERS
·
Jun 22

CARsgen Therapeutics Gets Nod for Gastric Cancer Drug Application in China

MT Newswires Live
·
Jun 22

CARsgen gains NMPA approval for satri-cel, the world’s first CAR T therapy targeting solid tumors

Bulletin Express
·
Jun 22

CARSGEN-B Receives NMPA Approval for Claudin18.2 CAR-T Therapy Kelimei®

Stock News
·
Jun 22

CARsgen Therapeutics - Nmpa Approves Satricabtagene Autoleucel for Advanced Gastric/Gastroesophageal Cancer

THOMSON REUTERS
·
Jun 22

Hong Kong Shares Surge as CARSGEN-B Achieves Landmark Approval for First Solid Tumor CAR-T Therapy

Stock News
·
Jun 22

China approves CARsgen Therapeutics satricabtagene autoleucel 'satri-cel' injection

Reuters
·
Jun 22

How Early Allogeneic CAR T Results At CARsgen (SEHK:2171) Have Changed Its Investment Story

Simply Wall St.
·
Jun 19

CARsgen Therapeutics Holdings (SEHK:2171) Stock Looks Rich Even After New CAR T Data

Simply Wall St.
·
Jun 16

Shares of CARSGEN-B Surge Over 5% Following EHA Poster Presentations for CT0596 and CT1190B

Stock News
·
Jun 15

CARsgen releases fresh EHA data on allogeneic CAR-T candidates CT0596 and CT1190B; Phase Ib studies targeted for 2026

Bulletin Express
·
Jun 15